- Report
- October 2025
Global
From €4372EUR$4,900USD£3,855GBP
- Report
- June 2024
- 209 Pages
Global
From €3792EUR$4,250USD£3,344GBP
Pouchitis is an inflammation of the ileal pouch, a surgically created reservoir used to replace the large intestine in patients with ulcerative colitis. It is a common complication of ileal pouch-anal anastomosis (IPAA) surgery, and is estimated to affect up to 20% of patients. Symptoms of pouchitis include abdominal pain, diarrhea, and rectal bleeding. Treatment options include antibiotics, probiotics, and immunosuppressants.
The pouchitis market is a subset of the larger gastroenterology market, which is estimated to reach $50 billion by 2027. Companies in the pouchitis market include AbbVie, Allergan, AstraZeneca, Janssen, and Takeda. Show Less Read more